Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.28877
Abstract: Key Points Question Is there equitable geographic access to chimeric antigen receptor–T cells (CAR-T) and bispecific antibodies trials for multiple myeloma in the US? Findings In this cross-sectional study of data from 69 clinical trials…
read more here.
Keywords:
trials multiple;
multiple myeloma;
antibodies trials;
access chimeric ... See more keywords